12/15/20 12:09 | 12/11/20 | FPRX | Five Prime Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Smith David V | CA | O | EVP,CFO | M.d | 0 | 0.00 | 0 | 22 | 39 | 78 | D | | | | | | | | | | | | | | |
11/13/20 12:29 | 11/11/20 | FPRX | Five Prime Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Smith David V | CA | O | EVP,CFO | M.d | 0 | 0.00 | 0 | 22 | 42 | 74 | D | | | | | | | | | | | | | | |
4/5/18 13:11 | 4/3/18 | CDXS | Codexis Inc | | Chem | OChm | Industrial Organic Chemicals | Smith David V | CA | D | | S | -62 | 10.37 | 0 | -6 | -10 | 57 | I | | | | | | | | | | | | | | |
5/24/16 13:19 | 5/20/16 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Smith David V | WA | D | | M.d | 0 | 0.00 | 1 | 3 | 36 | 10 | D | -76 | -51 | -61 | 48 | 20 | -12 | 8 | -10 | 8 | 11 | 14 | -36 | -46 | |
5/22/15 09:34 | 5/20/15 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Smith David V | WA | D | | M.d | 0 | 0.00 | 0 | 3 | 56 | 7 | D | -82 | -49 | -12 | -17 | -21 | -4 | 6 | 1 | -2 | 12 | 48 | 32 | 23 | -53 |
6/9/14 12:50 | 6/5/14 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Smith David V | WA | D | | M.d | 0 | 0.00 | 1 | 3 | 125 | 5 | D | -72 | -65 | -56 | -72 | -64 | -9 | -15 | 3 | 1 | -5 | -3 | -11 | -35 | -25 |
5/28/13 12:34 | 5/23/13 | OGXI | Oncogenex Pharmaceuticals, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Smith David V | WA | D | | M.d | 21 | 10.64 | 1 | 2 | New | 2 | D | -32 | -17 | -10 | -10 | 3 | 3 | 6 | 3 | -1 | -4 | -12 | -14 | -25 | -64 |
6/7/10 17:01 | 6/3/10 | THOR | Thoratec Corp | CA | Health | ElcMd | Electromedical & Electrothera | Smith David V | CA | O | CFO,EVP | M.d | 527 | 17.58 | 33 | 30 | 106 | 58 | D | 148 | 71 | 38 | 34 | 25 | 4 | 2 | 0 | -1 | 5 | 1 | -21 | -40 | -23 |
6/7/10 17:01 | 6/3/10 | THOR | Thoratec Corp | CA | Health | ElcMd | Electromedical & Electrothera | Smith David V | CA | O | CFO,EVP | S.d | -1,331 | 44.37 | 33 | -30 | -34 | 58 | D | 148 | 71 | 38 | 34 | 25 | 4 | 2 | 0 | -1 | 5 | 1 | -21 | -40 | -23 |